A Blueprint for Advancing Genetics-Based Cancer Therapy

In the era of next-generation sequencing, there are significant challenges to harnessing cancer genome information to develop novel therapies. Key research thrusts in both academia and industry will speed this transition, and lessons learned for cancer will more broadly shape the process for genetic...

Full description

Saved in:
Bibliographic Details
Published inCell Vol. 147; no. 1; pp. 26 - 31
Main Author Sellers, William R.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 30.09.2011
Subjects
Cancer
Chromosome Aberrations
genome
Genome, Human
Genomes
high-throughput nucleotide sequencing
Humans
industry
Mutation
Neoplasms - genetics
Neoplasms - therapy
therapeutics
therapy
Online AccessGet full text

Cover

More Information
Summary:In the era of next-generation sequencing, there are significant challenges to harnessing cancer genome information to develop novel therapies. Key research thrusts in both academia and industry will speed this transition, and lessons learned for cancer will more broadly shape the process for genetic contributions to the therapy of disease more broadly.
Bibliography:http://dx.doi.org/10.1016/j.cell.2011.09.016
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0092-8674
1097-4172
DOI:10.1016/j.cell.2011.09.016